Articles

miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells

Inserm, UMR1037 CRCT, F-31000 Toulouse, France;Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France;CNRS, ERL5294 CRCT, F-31000 Toulouse, France
Inserm, UMR1037 CRCT, F-31000 Toulouse, France;Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France;CNRS, ERL5294 CRCT, F-31000 Toulouse, France
Inserm, UMR1037 CRCT, F-31000 Toulouse, France;Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France;CNRS, ERL5294 CRCT, F-31000 Toulouse, France
Inserm, UMR1037 CRCT, F-31000 Toulouse, France;Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France;CNRS, ERL5294 CRCT, F-31000 Toulouse, France
Laboratoire d’Ingénierie des Systèmes Biologiques et des Procédés, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France
Inserm, UMR1037 CRCT, F-31000 Toulouse, France;Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France;CNRS, ERL5294 CRCT, F-31000 Toulouse, France
Inserm, UMR1037 CRCT, F-31000 Toulouse, France;Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France;CNRS, ERL5294 CRCT, F-31000 Toulouse, France;Institut Carnot Lymphome-CALYM, F-31024 Toulouse, France;Laboratoire d’Excellence Toulouse Cancer-TOUCAN, F-31024 Toulouse, France;European Research Initiative on ALK-Related Malignancies, Cambridge, UK
Inserm, UMR1037 CRCT, F-31000 Toulouse, France;Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France;CNRS, ERL5294 CRCT, F-31000 Toulouse, France;Institut Carnot Lymphome-CALYM, F-31024 Toulouse, France;Laboratoire d’Excellence Toulouse Cancer-TOUCAN, F-31024 Toulouse, France;European Research Initiative on ALK-Related Malignancies, Cambridge, UK
Inserm, UMR1037 CRCT, F-31000 Toulouse, France;Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France;CNRS, ERL5294 CRCT, F-31000 Toulouse, France;Institut Carnot Lymphome-CALYM, F-31024 Toulouse, France;Laboratoire d’Excellence Toulouse Cancer-TOUCAN, F-31024 Toulouse, France;European Research Initiative on ALK-Related Malignancies, Cambridge, UK
Vol. 104 No. 2 (2019): February, 2019 https://doi.org/10.3324/haematol.2018.195131